Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19

Overview of attention for article published in ACS Pharmacology & Translational Science, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 320)
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 34 tweeters

reddit: 2 Redditors

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Twitter Reddit Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Glycan Nanostructures of Human Coronaviruses

Article in International Journal of Nanomedicine (July 2021)

COVID-19 and Ivermectin: Potential threats associated with human use

Article in Journal of Molecular Structure (June 2021)

Recent Advances on Nanomaterials to COVID‐19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS‐CoV‐2 Inhibition/Inactivation

Article in Global Challenges (February 2021)